PUBLICATIONS

HPB Medicine


Authors : Professor Andrew Burroughs, Dr David Patch

FORMAT TITLE (click to view)
pdfExploring the Bidirectional Interactions Between Human Cytomegalovirus and Hepatitis C Virus Replication After Liver Transplantation (2007)
pdfImmunogenicity and Safety of an Experimental Adjuvanted Hepatitis B Candidate Vaccine in Liver Transplant Patients (2006)
pdfIncidence and Risk Factors for the Development of Prolonged and Severe Intrahepatic Cholestasis After Liver Transplantation (2006)
pdfReview article: scoring systems for assessing prognosis in critically ill adult cirrhotics (2006)
pdfNutritional status and prognosis in cirrhotic patients
pdfModelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis (2006)
pdfLiver Transplantation and Recurrent Hepatocellular Carcinoma: Predictive Value of Nodule Size in a Retrospective and Explant Study (2006)
pdfRelief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting (2006)
pdfReport of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis (2006)
pdfEffect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study (2006).
pdfA systematic review of the quality of liver biopsy specimens (2006)
pdfSpontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? (2006)
pdfTransjugular liver biopsy: how good is it for accurate histological interpretation? (2006)
pdfRejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis (2006)
pdfKing’s Criteria, APACHE II, and SOFA Scores in Acute Liver Failure (2006)
pdfTransjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation (2006)
pdfAn appraisal of the histopathological assessment of liver fibrosis (2006)
pdfLength versus width in liver biopsies
pdfThe effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays (2006)
pdfInduction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus
pdfLiver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres (2006)
pdf3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome (2006)
pdf Is Banding Ligation for Primary Prevention of Variceal Bleeding as Effective as Beta-Blockers, and Is It Safe? (2006)
pdfTransjugular Intrahepatic Portosystemic Shunt (TIPS), the Preferred Therapeutic Option for Budd Chiari Syndrome Associated with Portal Vein Thrombosis (2007)
pdfRisk factors, Sequential Organ Failure Assessment and Model for End-stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit (2007)
pdfHepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis
pdfAdrenal insufficiency in liver disease – What is the evidence?
pdfUltrasound-guided liver biopsy in real life: Comparison of same-day prebiopsy versus real-time ultrasound approach (2007)
pdfTransjugular liver biopsy – Indications, adequacy, quality of specimens, and complications – A systematic review (2007)
pdfAn economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis.
pdfTowards a Better Liver Transplant Allocation System (2007)
pdfSeeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC
pdfTransjugular liver biopsy in patientswith di¡use liver disease: comparison of three coreswith one or two cores for accurate histological interpretation (2007)
pdfThe effects of glycosaminoglycans on coagulation: a thromboelastographic study (2007)
pdfNoninvasive Tests in the Post–Liver Transplantatio Setting (2007)
pdfCONDUCTION AND EXCITABILITY PROPERTIES OF PERIPHERAL NERVES IN END-STAGE LIVER DISEASE (2007)
pdfSystematic Review of HVPG Measurement: Statistics Versus Clinical Applicability (2007)
pdfNon-invasive tests for liver fibrosis: Encouraging or discouraging results? (2007)
pdfA randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.(2007)
pdfLiver Transplantation for HCV Cirrhosis: Improved Survival in Recent Years and Increased Severity of Recurrent Disease in Female Recipients: Results of a Long Term Retrospective Study (2007)
pdfRepeated courses of transarterial embolization with polyvinyl alcohol particles: ‘long life elixir’ in a cirrhotic patient with unresectable hepatocellular carcinoma (2007)
pdfDifferent Methods of Creatinine Measurement Significantly Affect MELD Scores (2007)
pdfTransjugular Intrahepatic Portosystemic Shunt for Portal Vein Thrombosis with and Without Underlying Cirrhosis (2007)
pdfUnmasking of -Fetoprotein-Specific CD4 T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization (2007)
pdfPrevention of the development of varices and first portal hypertensive bleeding episode (2007)
pdf Late Intrahepatic Hematoma Complicating Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome (2007)
pdfNew insights into the coagulopathy of liver disease and liver transplantation (2006)
pdfThe transjugular route: The key hole to the liver world (2007)
pdfExploring the Bidirectional Interactions Between Human Cytomegalovirus and Hepatitis C Virus Replication After Liver Transplantation (2006)
pdfPrimary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation (2006)
pdfRandomized Controlled Trial of Tacrolimus Versus Microemulsified Cyclosporin (TMC) in Liver Transplantation: Post study Surveillance to 3 Years (2006)
pdfTransarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized studies (2006)
pdfTreatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies (2006)
pdfTransjugular intrahepatic portosystemic shunt in the in the management of ascites and hepatorenal syndrome (2006)
pdfThe The Low Incidence of Bacterial Infections Could Be a Protective Factor Against Variceal Bleeding Per Se in Hemodynamic Responders to Propranolol (2006)
pdfAn evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye(2006_
pdfAn evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye
pdfPrimary Herpes Simplex Virus in type -2 infection as a cause of liver failure after liver transplantation (2006)
pdfDifferent methods of creatinine measurement significantly affects MELD scores (April 2006)
pdfConduction and excitability properties of peripheral nerves in end stage liver disease
webEffect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. May 2006
webA systematic review of the quality of liver biopsy specimens. May 2006
pdfAn appraisal of the histopathological assessment of liver fibrosis. April 2006
pdfLength versus width in liver biopsies. April 2006
pdfTransjugular liver biopsy: how good it is for accurate histological interpretation? April 2006
pdfRisk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. April 2006
pdfKing's criteria, APACHE II, and SOFA scores in acute liver failure. April 2006
webThe effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. March 2006
pdfTransjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. March 2006
pdfClinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. March 2006
pdfSpontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? March 2006
pdfRejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. March 2006
pdfLiver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. March 2006
webInduction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. February 2006
pdf3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. January 2006
pdf Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe? January 2006
pdfEndogenous heparinoids in acute variceal bleeding. January 2006
pdfMonitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. January 2006
pdfInfection, coagulation, and variceal bleeding in cirrhosis. January 2006
pdfMonitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions. January 2006
pdfKinetics of Cytomegalovirus Load Decrease in Solid-Organ Transplant Recipients after Preemptive Therapy with Valganciclovir. January 2006
pdfClinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. January 2006
pdfBeta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. November 2005
pdfBleeding ectopic varices—treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. October 2005
pdfSystematic review: the model for end-stage liver disease – should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? September 2005
pdfAntiviral treatment after solid organ transplantation. September 2005
pdfThe relationship between liver function and portal pressure: what comes first, the chicken or the egg? September 2005
pdfSustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis. September 2005
pdfShould we biopsy each liver mass suspicious for HCC before liver transplantation?–No, please don’t. August 2005
pdfObstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen’s disease. July 2005
pdfAssessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. May 2005
pdfMELD is not enough—enough of MELD? April 2005
pdf Primary prophylaxis of variceal bleeding in cirrhotics unable to take b-blockers: a randomized trial of ligation. March 2005
pdf Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model. January 2005
pdfReview article: portal vein thrombosis – new insights into aetiology and management. October 2004
pdfLong-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. October 2004
pdf Extensive Homology between the Major Immunodominant Mitochondrial Antigen in Primary Biliary Cirrhosis and Helicobacter pylori Does Not Lead to Immunological Cross-reactivity. April 2004